- Message from the Director
- Chair, Board of Governors Message
- Board of Governors
- Leadership
- Sylvester Locations
- Sylvester by the Numbers
-
- Sylvester Investigator’s Hodgkin Lymphoma Protocol Could Change Care for Relapsed, Refractory Patients
- Sylvester Physician-Scientist Receives Doris Duke Charitable Foundation Grant
- Junior Researcher Lands Competitive Grants for Pancreatic Cancer Focus
- Sylvester Researcher Chosen for Bristol Myers Squibb Foundation’s Career Development Program
- Sylvester Part of Groundbreaking NIH Trial Proving Anal Cancer Can Be Prevented
- The Childhood Cancer Project Focuses On Cures
-
- Health Economist Heads Commission to Examine Global Cancer Care Inequities
- Dr. Chad Ritch Appointed Member of American College of Surgeons Commission on Cancer
- Sylvester Launches New Program To Prevent Breast Cancer In Those At High Risk
- VA Honors Investigator For Gastric Cancer Research
- Keeping Cancer In Its Place: Key Protein Identified
- Phase 1 Program
-
- WHO Taps Sylvester in Global Fight Against Cervical Cancer
- Groundbreaking Research
- Community Outreach
- Orthopaedic Surgeon, Researcher Dr. Francis Hornicek Returns To Miami
- Sarcoma Specialist’s Return Elevates Sylvester Orthopaedic Oncology
- Dr. Marijo Bilusic Joins Sylvester as Genitourinary Site Leader
- Cancer Control Leader Joins Sylvester
- Educational Pathways Fuel Robust Cancer Research Pipeline
- Target: Multiple Myeloma Cure
- Educator
-
- Committed to Survivors’ Quality of Life
- Multidisciplinary Clinic
- Tackling Hispanic Cancer Disparities
- Training The Next Generation of Researchers in Disparities, Equity
- Researcher Drives Efforts To Educate Youth About E-Cigs, Hookahs
- Sylvester Studies Cancer Patient Advocacy Group’s Impact on Outcomes
- Clinic Addresses Sexual Dysfunction In Cancer Survivors
-
Fulvia Verde, Ph.D., a Sylvester researcher, will soon be sending an array of fission yeast cells on a 60-day space mission. Called Artemis 1, the NASA project will take the yeast and other samples to the moon and back. Dr. Verde’s cells will be joined by four other science payloads aboard the rocket.
Around 4,000 of Dr. Verde’s yeast colonies are being sent into space. Each colony is missing a single gene, giving the team unique opportunities to identify which gene deletions protect the yeast in this hostile environment. These findings might eventually be translated into treatments that protect humans during long space flights.
After the yeast cells return, the researchers will study their response to ionizing radiation and microgravity and hopefully identify protective genes. The goal is to make long human space missions safer.
“The International Space Station is in the upper layer of the atmosphere, so it’s quite protected from ionizing radiation,” said Dr. Verde, who is also an associate professor of molecular and cellular pharmacology. “But then when you go further out, everything is blasted by particles, which can do a lot of cellular damage.”
To pursue this project, Dr. Verde received a grant from the Miller School of Medicine's High Risk/High Reward Funding Opportunity, which supports innovative research that might otherwise be difficult to fund.